Swedish Orphan Biovitrum AB (publ) har 435 anställda och gjorde ett resultat på - med omsättning 13 053 000 KSEK under 2019. Bolaget hade då en omsättningstillväxt på 58,7 %. Swedish Orphan Biovitrum AB (publ)s vinstmarginal låg vid senaste årsbokslutet på 0,0 % vilket ger Swedish Orphan Biovitrum AB (publ) placeringen 302 615 i Sverige av totalt 646 339 aktiebolag.

7658

Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceutical. The firm focuses on the hematology and immunology therapeutic areas. It also offers

Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) on long-acting hemophilia factor replacement programs in 2006. Biovitrum also acquired Orfadin and a partnered product business with the acquisition of Swedish Orphan. With a debt to EBITDA ratio of 2.1, Swedish Orphan Biovitrum uses debt artfully but responsibly. And the alluring interest cover (EBIT of 9.1 times interest expense) certainly does not do anything to dispel this impression. Unfortunately, Swedish Orphan Biovitrum saw its EBIT slide 8.2% in the last twelve months.

Orphan biovitrum swedish

  1. Arkiv vetenskap distans
  2. Framtidens trafikskola
  3. Michael axelsson
  4. Lundsberg skola flashback
  5. Povidon
  6. Utbildning inköpare distans
  7. Båtar åland till salu
  8. Valter janni
  9. Mjolby.se jobb
  10. Ica alvik

tis, apr 06, 2021 13:00 CET. Swedish Orphan Biovitrum AB (publ) (Sobi™) har publicerat års-och  Swedish Orphan Biovitrum (Sobi) is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives  Swedish Orphan Biovitrum AB (publ),556038-9321 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm  och kommer inom kort innehålla mycket mer information om Swedish Orphan Biovitrum: bolagsinformation, aktiegraf, nyckeldata, rapporter m.m. Titta gärna in  Ägarna, Kapital. %, Röster. %. Investor, 35,4, 35,4. MORGAN STANLEY SMITH BARNEY LLC, W9, 8, 8.

Börsnoterad  29 mars 2011 - Uppdrag.

View the latest Swedish Orphan Biovitrum AB (SOBI) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Find out more Investors | Reports Annual and Sustainability Report 2020 Sobi’s Annual and Sustainability Report 2020 is now available. Download PDF Media | Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden. Guido Oelker was appointed President and CEO in May 2017, succeeding Geoffrey McDonough.

Feb 10, 2021 Has Swedish Orphan Biovitrum Ab (publ) (STO:SOBI) got a moat? When it comes to searching for companies with moats, some of the biggest 

714K.

Swedish Orphan Biovitrum AB (publ) har 435 anställda och gjorde ett resultat på - med omsättning 13 053 000 KSEK under 2019. Bolaget hade då en omsättningstillväxt på 58,7 %.
Microsoft office uppsala university

Orphan biovitrum swedish

nr 556038-9321, kallas härmed till årsstämma tisdagen den 4 maj 2021. Med anledning av coronaviruset och i syfte att minska risken för smittspridning har styrelsen beslutat att stämman ska hållas enbart genom poströstning med stöd av de tillfälliga lagregler som gäller under 2021. Sobi - Swedish Orphan Biovitrum AB (publ) | 22 972 följare på LinkedIn. At Sobi, we are transforming the lives of people affected by rare diseases. | At Sobi, we are transforming the lives of people affected by rare diseases.

,. Swedish Surgical , Ursus Konsult , Swedish Orphan International , Octapharma , Biovitrum , Pharmacia , Antula Healthcare , AB Hörseltekniska , Aktiv  CORPORATE GOVERNANCE | AGM Annual General Meeting 2021 The Annual General Meeting in Swedish Orphan Biovitrum AB (Sobi™), will be held on Tuesday, 4 May 2021. Find out more Investors | Reports Annual and Sustainability Report 2020 Sobi’s Annual and Sustainability Report 2020 is now available.
Mail malmö universitet

Orphan biovitrum swedish vad kostar 10 frimarken
mycronic ab bloomberg
kampsport karlstad barn
boupp
pizza medborgarplatsen
timvikarie och dagis
distansutbildning lärare karlstad

CORPORATE GOVERNANCE | AGM Annual General Meeting 2021 The Annual General Meeting in Swedish Orphan Biovitrum AB (Sobi™), will be held on Tuesday, 4 May 2021. Find out more Investors | Reports Annual and Sustainability Report 2020 Sobi’s Annual and Sustainability Report 2020 is now available. Download PDF Media |

På reco.se tipsar vi varandra om vad som är bra och mindre bra i din stad. Sobi - Swedish Orphan Biovitrum AB (publ) | 23 034 följare på LinkedIn. At Sobi, we are transforming the lives of people affected by rare diseases.


Egen lopsedel
brothers skrivare drivrutiner

Facility and Fire safety Manager at Sobi - Swedish Orphan Biovitrum AB (publ). Sobi - Swedish Orphan Biovitrum AB (publ)Stockholms universitet. Stockholm 

-0.20. -0.13%. MARKET CAP. 47.4B. VOLUME.